Dr Ioanna Nixon

Dr Ioanna Nixon is a Clinical Oncologist specialising in the treatment of Soft Tissue Sarcomas, Bone Sarcomas and GISTS. As a clinical oncologist she offers both radiotherapy and drug therapies. She is also a Visiting Professor at Strathclyde University.

Dr Nixon holds National leadership roles as the Clinical Lead for the Scottish Sarcoma Network, Chair for the Regional Quality Improvement Group (jointly with Dr Peter Thomson). She served as the UK Chair for the NCRI (National Cancer Research Institute) Head and Neck epidemiology and survivorship subgroup and board member of the New Drugs Committee.  She is a Board member of the British Sarcoma Group and a member of the NCRI Soft Tissue Sarcoma Clinical Research Group(CSG).

Her main research interests are novel therapies for soft tissue sarcomas, patient experience and clinical innovations. She is Principle investigator in a number of National and International clinical trials and she and colleagues have a research portfolio for patients with sarcoma diagnosis.

She has been awarded with a PhD in Radiotherapy, a Master in Public Health (MPH:Epidemiology) degree and is a Scottish Quality and Safety (SQS) Fellow. She holds developmental roles as an educational supervisor for junior doctors and specialty trainees in oncology and an appraiser for NHS Consultants. She is  also an  academic mentor for PhD students and a  mentor in National Leadership Programmes, including the Scottish Improvement Leader’s programme by NES.

In 2018 she was awarded as a Founding Fellow of Faculty of Medical Leadership and Management(FMLM) for leadership and  contribution to improving patient-centered care and recently as Honorary Fellow of the Royal College of Radiologists(FRCR). Her team has been finalists for the BMJ Awards Cancer Team of the Year 2020